Since the completion of the human genome project in 2003, structural and genetic factors within the genome are continuously being mapped to various diseases previously not considered to have genetic ...

Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Optical Genome Mapping Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's ...

Bionano announced a significant study published in the American Journal of Hematology demonstrating the utility of optical genome mapping (OGM) in detecting structural variants associated with ...

SAN DIEGO, June 18, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) recently participated in the European Society of Human Genetics (ESHG) conference held in Milan, Italy, from May 24-27, ...

Brain tumors are a leading cause of cancer-related mortality in children. Research shows that structural variants (SVs) play an important role in tumorigenesis and growth. However, most genetic ...

Optical Genome Mapping for diagnosis of paediatric leukaemia Cytogenetics has led to the discovery of multiple chromosomal anomalies associated with hemato-oncologic diseases in children and ...

SAN DIEGO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced Bionano Symposium 2026, the premier global event for the optical genome mapping (OGM) community. This virtual ...

SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced a peer-reviewed publication from a team led by Manon Delafoy from the Institut Necker Enfants Malades (INEM) ...

The scientific program for the event is available at the ESHG website linked here https://cattendee.abstractsonline.com/meeting/21105/pages/Scientific_Programme?view ...